Filing metadata

Accession number
0001104659-19-059645
Form type
Form 4
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
Nov 04, 2019
Reporting period
Nov 04, 2019
Description
Insider transaction

Explore SEC Filings Hub